Pelanserin

This classification denotes a serotonin antagonist with the molecular formula C21H24N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6SNR96E409, chemically known as 2,4(1h,3h)-quinazolinedione, 3-(3-(4-phenyl-1-piperazinyl)propyl)- but generally known as pelanserin, which bears US NIH Compound Identifier 65435. European Medicines Agency schedules Pelanserin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09648MIG. The term PELANSERIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). PELANSERIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Pelanserin under HS 29335995 and SITC 51576. As of Q4 2014, PELANSERIN remains the US FDA Preferred Term for this commodity. Pelanserin bears US NLM identifiers UMLS ID C0070209 and NCI Concept Code C76965. SMILES: C1CCC(CC1)N2CCN(CC2)CCCN3C(=O)C4CCCCC4[NH]C3=O.